Welcome new member, Alexion Pharmaceuticals. Alexion's mission is to transform the lives of people affected by rare diseases and devastating conditions by continuously innovating and creating meaningful value in all they do. https://alexion.com/ | The New England Council
0:21
Welcome new member, Alexion Pharmaceuticals. Alexion's mission is to transform the lives of people affected by rare diseases and devastating conditions by continuously innovating and creating meaningful value in all they do. https://alexion.com/ | The New England Council
7 viewsNov 17, 2023
FacebookThe New England Council
Alexion Pharmaceuticals, Inc. Vise à faire progresser le paysage des traitements de la Nmosd avec des données exceptionnelles sur l'efficacité d'Ultomiris® (Ravulizumab-Cwvz) à Ectrims 2022
Alexion Pharmaceuticals, Inc. Vise à faire progresser le paysage des traitements de la Nmosd avec des données exceptionnelles sur l'efficacité d'Ultomiris® (Ravulizumab-Cwvz) à Ectrims 2022
Oct 12, 2022
zonebourse.com
Will New Drug Give Alexion Pharmaceuticals A Boost?
4:25
Will New Drug Give Alexion Pharmaceuticals A Boost?
Jul 18, 2014
investors.com
2025 marks 10 years of the Alexion-sponsored Global HPP Registry (#HPP). As the largest observational study in this #raredisease, the registry helps to increase understanding of HPP and inform the science leading to new innovations for this community. | Alexion Pharmaceuticals
0:15
2025 marks 10 years of the Alexion-sponsored Global HPP Registry (#HPP). As the largest observational study in this #raredisease, the registry helps to increase understanding of HPP and inform the science leading to new innovations for this community. | Alexion Pharmaceuticals
51 views7 months ago
FacebookAlexion Pharmaceuticals
Meg was 15 years old when she began experiencing weight loss, hair loss, and fatigue–symptoms which were initially dismissed by doctors. Eventually, she was diagnosed with #NMOSD, a #RareDisease. Learn about her journey and why Meg is raising awareness of NMOSD. | Alexion Pharmaceuticals
3:40
Meg was 15 years old when she began experiencing weight loss, hair loss, and fatigue–symptoms which were initially dismissed by doctors. Eventually, she was diagnosed with #NMOSD, a #RareDisease. Learn about her journey and why Meg is raising awareness of NMOSD. | Alexion Pharmaceuticals
40 views6 months ago
FacebookAlexion Pharmaceuticals
Alexion Receives FDA Approval for New Advanced Formulation of ULTOMIRIS® (ravulizumab-cwvz) with Significantly Reduced Infusion Time
Alexion Receives FDA Approval for New Advanced Formulation of ULTOMIRIS® (ravulizumab-cwvz) with Significantly Reduced Infusion Time
Oct 12, 2020
marketscreener.com
Rare Connections in NMOSD | Alexion Pharmaceuticals, Inc.
Rare Connections in NMOSD | Alexion Pharmaceuticals, Inc.
447.4K views1 month ago
linkedin.com
AstraZeneca Agrees $39 Billion Takeover of Alexion Pharmaceuticals
Dec 12, 2020
thestreet.com
1:02
Alexion shares down amid HHS investigation
Jul 6, 2017
CNBC
Alexion Pharmaceuticals, Inc. Announces New Data from Phase 3 REGAIN Study of Eculizumab (Soliris®) in Patients with Refractory Generalized Myasthenia Gravis Presented at ICNMD Annual Congress
Jul 7, 2016
marketscreener.com
Alexion CEO: We are thrilled with FDA approval
Dec 10, 2015
CNBCMeg Tirrell
“Absorberá” AstraZeneca a farmacéutica Alexion por casi ¡40 mmdd!
Dec 13, 2020
tiempo.com.mx
Alexion Pharmaceuticals, Inc. | LinkedIn
Jan 1, 2009
linkedin.com
1:37
Collaboration at Alexion
110 viewsDec 17, 2014
YouTubeRare Disease Report
1:28
Alexion Pharmaceuticals is reportedly planning to move its corporate headquarters from New Haven to Boston. That and more top stories from News 8. | WTNH News 8
16.5K viewsSep 12, 2017
FacebookWTNH News 8
Acuerdo con AstraZeneca impulsa acciones de Alexion
Sep 1, 2020
elceo.com
3:14
Alexion CEO & CFO out
Dec 12, 2016
CNBC
5:16
S&P 500 | Alexion Pharmaceuticals: Quick 5-Min Overview
133 viewsDec 31, 2023
YouTubeBruno Invest
AstraZeneca to buy Alexion for $39 billion to expand in immunology
Dec 12, 2020
Fox BusinessFox Business
Alexion Pharmaceuticals Nabs an Approval, Wall Street Not Impressed
Oct 4, 2019
nasdaq.com
1:41
Alexion Pharmaceuticals moving HQ from New Haven to Boston
Feb 25, 2020
fox61.com
0:45
AstraZeneca buying Alexion Pharmaceuticals in $39 Billion deal
Dec 12, 2020
fox61.com
2:19
Alexion CEO: 'We're moving on' from shakeup
Jan 9, 2017
CNBC
Lookback: Miller Value Partners 2019 Alexion Pharmaceuticals (ALXN) Thesis
Nov 30, 2020
insidermonkey.com
Should You Be Tempted To ‘Sell’ Alexion Pharmaceuticals (ALXN) Stock
Jun 11, 2020
insidermonkey.com
Alexion Pharma rocked by top executive firings amid drug sales investigation
Dec 6, 2019
thestreet.com
3:36
AstraZeneca to buy Alexion Pharmaceuticals in $39 billion deal
Dec 14, 2020
CNBC
AstraZeneca to Buy Alexion in $39 Billion Deal
Dec 14, 2020
Bloomberg.comTim Loh,Eric Pfanner
AstraZeneca eyes big jump in revenue after Alexion acquisition
Jul 29, 2021
proactiveinvestors.co.uk
1:20
Alexion Celebrates Opening of New Global Headquarters in New Haven
Mar 1, 2016
nbcconnecticut.com
See more
Static thumbnail place holder